![]() |
市場調查報告書
商品編碼
2016164
注射器市場報告:按產品、材料、應用、分銷管道、最終用戶和地區分類(2026-2034 年)Syringes Market Report by Product, Material, Usage, Distribution Channel, End User, and Region 2026-2034 |
||||||
2025年全球注射器市場規模達225億美元。預計到2034年將達到402億美元,2026年至2034年的複合年成長率為6.44%。政府為促進民眾快速安全地接種疫苗而採取的支持措施是市場成長的關鍵促進因素。
對先進注射器的需求
新技術的引入提升了注射器的安全性和功能性,這對注射器市場的前景產生了積極影響。例如,2024年3月,領先的自動失效一次性注射器製造商之一——印度斯坦注射器和醫療器械公司(HMD)宣布推出“Dispojekt”,這是一款國產一次性安全注射器,旨在最大限度地減少針刺傷。此外,2024年5月,總部位於德國的醫療保健和藥品包裝公司Geresheimer宣布擴建位於墨西哥克雷塔羅的工廠,以滿足北美市場的需求,提高其即用型(RTF)注射器的產能。此外,居家醫療偏好的轉變以及生物製藥的日益普及也在推動市場發展。例如,2024年3月,藥品容器解決方案和給藥系統供應商肖特製藥(SCHOTT Pharma)在威爾遜建立了其在美國的首家工廠,用於生產預灌封聚合物注射器,以滿足mRNA藥物低溫儲存和運輸的需求。該工廠還能夠生產用於 GLP-1 療法的玻璃預灌封注射器,包括用於治療糖尿病和肥胖症的藥物。
慢性病的蔓延
隨著癌症、糖尿病和心血管疾病等慢性病發病率的不斷上升,使用注射器進行規律、精準給藥的需求日益成長。歐洲藥物和藥物依賴監測中心 (EMCDDA) 和歐洲疾病預防控制中心 (ECDC) 於 2023 年 11 月發布的一份報告評估了預防人際感染疾病干預措施的有效性,其中包括針具交換計畫 (NSP)。此外,胰島素注射器在糖尿病常規管理中的廣泛應用也推動了市場成長。例如,2023 年 11 月,Terumo Corporation印度公司推出了一款胰島素注射器,這是一款適用於需要定期注射胰島素患者的無菌給藥裝置。這是Terumo Corporation醫療解決方案公司生命關懷解決方案部門的新產品。這款注射器採用高品質矽膠表面,配備三面拋光的超鋒利針頭,為患者提供更溫和、更舒適的使用體驗。其獨特的活塞固定技術可防止藥物浪費和洩漏。此外,根據美國糖尿病協會 (ADA) 估計,美國有數百萬人需要注射胰島素,這推動了對可靠且易於使用的注射器的需求。
人們越來越關注安全問題
醫療機構對感染控制的日益重視正在推動先進注射器技術的應用。例如,2024年5月,無菌注射小分子藥物、生物製藥和疫苗的契約製造製造商Grand River Aseptic Manufacturing (GRAM)擴大了其注射器和藥筒的產能,以滿足不斷成長的生物製藥研發管線以及行業內用於患者自我給藥的先進給藥系統的發展需求。此外,政府機構實施的嚴格法規,強制要求使用安全注射器以防止針刺傷,也是推動市場進一步成長的另一個關鍵因素。例如,2024年3月,美國食品藥物管理局(FDA)建議美國醫療機構立即停止使用某些未經批准的中國製造的塑膠注射器。此建議不適用於預填充式注射器、玻璃注射器或用於口服或外用的注射器。因此,領先的製造商正在積極響應,推出必要的、高品質的醫療產品,這將進一步推動未來幾年的市場成長。例如,2024 年 3 月,醫療技術公司 BD(貝克頓·迪金森公司)擴大了在內布拉斯加州和康乃狄克州工廠的注射器國內生產,以滿足客戶需求。
The global syringes market size reached USD 22.5 Billion in 2025. Looking forward, the market is expected to reach USD 40.2 Billion by 2034, exhibiting a growth rate (CAGR) of 6.44% during 2026-2034. Favorable policies by government bodies for encouraging the fast and safe vaccination of individuals are among the factors fueling the market.
Demand for Advanced Syringes
The introduction of novel advancements for enhancing the safety and functionality of syringes is positively influencing the syringes market outlook. For example, in March 2024, Hindustan Syringes and Medical Devices (HMD), one of the leading manufacturers of auto-disable and disposable syringes, introduced Dispojekt, an indigenous single-use safety syringe to minimize instances of needle stick injuries. Besides this, in May 2024, Gerresheimer, a healthcare and pharmaceutical packaging company based in Germany, announced the expansion of its Queretaro facility in Mexico to increase the production capacities for ready-to-fill (RTF) syringes, thereby catering to the market demand in North America. Additionally, the shifting preference towards home-based healthcare, along with the elevating popularity of biologics, is also propelling the market. For instance, in March 2024, SCHOTT Pharma, one of the pharmaceutical drug containment solutions and delivery systems providers, built its first U.S. facility in Wilson to manufacture pre-fillable polymer syringes required to meet the need for deep-cold storage and transportation of mRNA medications. The site can further produce glass pre-fillable syringes for GLP-1 therapies, such as those that treat diabetes or obesity.
Prevalence of Chronic Diseases
The growing incidences of chronic diseases, including cancer, diabetes, cardiovascular disorders, etc., are escalating the need for regular and precise medication delivery via syringes. The report published by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the European Centre for Disease Prevention and Control (ECDC) in November 2023 assessed the effectiveness of interventions, including needle and syringe programs (NSPs), to prevent infections among individuals. Moreover, the widespread usage of insulin syringes for the daily management of diabetes is also bolstering the market. For instance, in November 2023, Terumo India launched an insulin syringe, a sterile delivery device for patients requiring regular insulin injections. It is the addition to the Life Care Solutions division of Terumo Medical Care Solutions. In line with this, specifically designed to have a 3-bevel super sharp needle with a high-grade silicone surface, the syringe is gentle and more comfortable for patients. Its unique feature with plunger retention technology avoids wastage and spillage. Furthermore, the American Diabetes Association estimated that millions of individuals in the U.S. require insulin injections, thereby driving the demand for reliable and user-friendly syringes.
Increasing Focus on Safety
There is a rising emphasis on improving infection control within healthcare settings, thereby stimulating the adoption of advanced syringe technologies. For example, in May 2024, Grand River Aseptic Manufacturing (GRAM), one of the sterile injectable contract manufacturers of small molecules, biologics, and vaccines, expanded its syringe and cartridge capacity to provide greater capacity for the industry's elevating biologics pipeline and the growth in advanced drug delivery systems for patient self-administration. Apart from this, the implementation of stringent regulations by government bodies that mandate the use of safety syringes to prevent needlestick injuries is further acting as a significant growth-inducing factor. For instance, in March 2024, the Food and Drug Administration (FDA) advised healthcare organizations in the U.S. to immediately transition away from using certain unauthorized plastic syringes made in China. The recommendations do not apply to pre-filled syringes, glass syringes, or syringes utilized for oral or topical purposes. Consequently, leading manufacturers are responding by introducing essential high-quality medical products, which will continue to bolster the market in the coming years. For example, in March 2024, BD (Becton, Dickinson and Company), one of the medical technology companies, elevated domestic manufacturing of syringes in Nebraska and Connecticut facilities, U.S., to cater to customer needs.
Among these, general syringes currently exhibit a clear dominance in the market
General syringes, essential tools in medical and healthcare settings, are continually evolving with advancements in technology and design aimed at improving safety, accuracy, and convenience. One of the notable launches is the Medtronic MiniMed 770G Insulin Pump System, which integrates advanced smart technology for precise insulin delivery, catering specifically to diabetes patients. General syringes improve user safety and reduce the risk of accidental injuries, thereby driving the segment's growth.
Currently, glass syringes hold the largest market share
Glass syringes are a crucial component in the medical field, valued for their durability, chemical resistance, and precise delivery capabilities. Unlike plastic syringes, they do not interact with the medications they contain, thereby making them ideal for administering highly reactive or sensitive drugs, such as biologics and certain vaccines. Their use is prominent in the pharmaceutical and biotechnology industries, where maintaining the integrity of the substance is paramount. In January 2024, Schreiner MediPharm, a Germany-based global provider of functional label solutions for the healthcare industry, developed barrier function labels that are generally designed to protect against oxygen ingress for drugs contained in COC syringes.
Disposable syringes hold the largest share in the market
Disposable syringes have become an indispensable tool in modern healthcare due to their convenience, affordability, and ability to reduce the risk of cross-contamination and infection significantly. Designed for single use, these syringes are typically made from plastic and come pre-sterilized, ensuring a high standard of hygiene. Their widespread adoption has been driven by health initiatives aiming to combat the spread of infectious diseases. According to the report by IMARC, the global disposable syringes market size reached US$ 15.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 27.4 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032.
The offline segment, which includes hospitals, clinics, and retail pharmacies, continues to dominate the market due to the immediate availability of products and the trust consumers place in physical purchases, especially for critical healthcare supplies. This traditional distribution method is bolstered by strong relationships between manufacturers and healthcare providers, ensuring a steady supply chain and reliable access to syringes. Conversely, the online segment is experiencing rapid growth, driven by the increasing adoption of e-commerce platforms in the healthcare sector. Online distribution offers significant advantages such as convenience, wider product availability, and competitive pricing, which are particularly appealing to individual consumers and smaller healthcare facilities. Major players in the market, like Becton Dickinson (BD) and Terumo, are leveraging digital platforms to expand their reach and enhance customer engagement.
Syringes play a critical role across various healthcare settings. In hospitals and clinics, they are indispensable for a wide range of procedures, from routine vaccinations and blood draws to administering medications and intravenous therapies. Their reliability and ease of use make them a staple in these high-demand environments. Diagnostic centers heavily rely on syringes for sample collection and diagnostic testing, ensuring accurate and sterile handling of specimens. Specialty centers, such as oncology and diabetes care facilities, utilize them for precise administration of treatments like chemotherapy and insulin, which require meticulous dosing and safety. Other settings, such as outpatient care centers and emergency medical services, depend on syringes for immediate, on-the-go medical interventions, highlighting their versatility and importance in diverse medical scenarios.
North America currently dominates the market
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
As per the syringes market overview, the rising prevalence of chronic diseases, increased vaccination efforts, and advancements in medical technology are acting as growth-inducing factors in North America. Moreover, in the United States, stringent safety regulations set by the Occupational Safety and Health Administration (OSHA) have led to the widespread adoption of safety-engineered syringes that are designed to minimize needlestick injuries and enhance user safety. Besides this, the American Diabetes Association estimated that millions of individuals in the U.S. require insulin injections, thereby escalating the use of reliable and user-friendly syringes. Furthermore, prominent players like Becton Dickinson (BD) and Novo Nordisk are leading the market with their advanced insulin delivery systems.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include: